Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07662512

Different Ozone Concentrations for Knee Osteoarthritis

Conditions: Knee Osteoarthristis, Gonarthrosis

Sex: All
Ages: 50 Years – 85 Years
Healthy volunteers: No
Phase: NA
Enrollment: 159
Sponsor: Sakarya University

Location: Sakarya University Adapazarı Sakarya

Summary

Knee osteoarthritis is a common condition that causes pain, stiffness, and difficulty with daily activities. Ozone injection therapy is a minimally invasive treatment that has been increasingly used to relieve symptoms in people with knee osteoarthritis. However, it is not clear whether different ozone concentrations produce different treatment outcomes. In this study, we compared the effects of two commonly used ozone concentrations (15 μg/mL and 25 μg/mL) in patients with knee osteoarthritis. A total of 159 patients received intra-articular ozone injections and were followed for 3 months. Pain, physical function, and quality of life were assessed before treatment and at 1 and 3 months after the injections.

Eligibility Criteria

Inclusion Criteria: * Patients aged 50-85 years with a diagnosis of primary knee osteoarthritis according to the American College of Rheumatology \[12\] criteria, symptomatic knee with KL \[13\] grades II, III and IV, who underwent intra-articular ozone treatment. Exclusion Criteria: * Patients with a history of any intra-articular injection within 3 months before the first ozone injection, a history of previous knee surgery, a diagnosis of malignancy, missing follow-up parameters, bilateral intra-articular knee ozone injection, a secondary knee osteoarthritis diagnosis (trauma, inflammatory joint disease, etc.), patients without demographic and clinical data, or direct radiographs.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07662512). StuddyBuddy aggregates publicly available trial information.